Saprochaete Capitata Peritonitis in a Non-neutropenic Patient Without Underlying Malignancies: A Case Report.

Cureus

Department of Biology/Department of Parasitology and Mycology, Faculty of Medicine and Pharmacy, Mohammed VI University Hospital, Cadi Ayyad University, Marrakesh, MAR.

Published: September 2023

() is an opportunistic arthroconidial yeast-like fungus causing invasive infections in immunocompromised patients, mainly those with hematological malignancies and severe neutropenia. However, infections due to are extremely rare in immunocompetent and non-neutropenic patients. spp. are microscopically characterized by arthroconidia with hyaline-septated hyphae. is known to be intrinsically resistant to echinocandins and highly resistant to fluconazole. It is suggested to use amphotericin B or voriconazole (in monotherapy or in combination) as the gold standard treatment for systemic infections. We report a rare case of peritonitis with fatal outcome in a non-neutropenic patient without underlying malignancies. This case report highlights the value of direct microscopic examination and stained smears in a prompt preliminary diagnosis of invasive fungal infections. We also aim to emphasize the importance of early initiation of appropriate antifungal treatment in patients with systemic infections, thus improving their therapeutic outcome.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585182PMC
http://dx.doi.org/10.7759/cureus.45568DOI Listing

Publication Analysis

Top Keywords

non-neutropenic patient
8
patient underlying
8
underlying malignancies
8
malignancies case
8
case report
8
systemic infections
8
infections
5
saprochaete capitata
4
capitata peritonitis
4
peritonitis non-neutropenic
4

Similar Publications

Background: Urinary tract infections are prone to overdiagnosis, and reflex urine culture protocols offer a valuable opportunity for diagnostic stewardship in this arena. However, there is no recommended standard testing approach. Cancer patients are often excluded from reflex urine culture protocols, especially if severely immunosuppressed or neutropenic.

View Article and Find Full Text PDF

The (1,3)-β-D-glucan use for invasive candidiasis diagnosis in non-neutropenic critically ill patients: a prospective cohort study.

Tunis Med

December 2024

University of Tunis El Manar, Faculty of Medicine of Tunis, La Rabta Tertiary Hospital, Intensive Care Medicine Department, 1007, Tunis, Tunisia.

Unlabelled: Introduction Invasive candidiasis (IC) is a widespread infection in intensive care. As culture-based diagnostic techniques take several days before positivity and leaks of sensitivity. (1,3)-β-D-glucan (BDG) was proposed as a mycological criterion for IC diagnosis in selected patients.

View Article and Find Full Text PDF

Bloodstream infections (BSIs) are a critical concern in pediatric onco-hematological patients undergoing chemotherapy or hematopoietic stem cell transplantation (HSCT), leading to a major impact on morbidity, long-term hospitalization, and mortality. We retrospectively analyzed 202 BSIs in 145 patients, consisting of 128 with hematological malignancies, one with a solid tumor, and 16 with non-malignant hematological diseases. We collected data on patient demographics, clinical characteristics, pathogen distribution, and antimicrobial pathogen susceptibility.

View Article and Find Full Text PDF

[Application of -specific immunoglobulin G antibody in the management of pulmonary aspergillosis].

Zhonghua Jie He He Hu Xi Za Zhi

December 2024

Department of Respiratory and Critical Care Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing210008, China.

causes a range of diseases in patients with immunodeficiency or underlying pulmonary diseases. -specific immunoglobulin G antibody (Asp-IgG) is produced in response to pathopoiesis. Currently, Asp-IgG is included in the diagnostic criteria for chronic pulmonary aspergillosis (CPA) and allergic bronchopulmonary aspergillosis (ABPA).

View Article and Find Full Text PDF
Article Synopsis
  • Candidemia is a major concern in critically ill patients, significantly affecting their morbidity and mortality, and is linked to various risk factors.
  • A retrospective study of 91 non-neutropenic critically ill adults examined the relationship between antifungal therapy effectiveness and patient outcomes, finding that improper or delayed treatment increased mortality rates.
  • Key risk factors for higher mortality included mechanical ventilation, vasopressor therapy, end-stage renal disease, and multiple organ failures; patients receiving inadequate antifungal therapy had a much higher mortality rate (64%) compared to those receiving appropriate treatment (29%).
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!